Literature DB >> 8884574

Neurological presentations of mitochondrial diseases.

M Zeviani1, B Bertagnolio, G Uziel.   

Abstract

We present here a report on a 5-year experience in clinical investigation, diagnostic management and molecular genetic studies of neuromitochondrial disorders, defined on the basis of morphological, biochemical and genetic findings. Leigh disease is the most frequent clinical presentation in infancy and childhood, but symptoms at onset are poorly informative. In paediatric cases, lactic acidosis and neuroradiological abnormalities are frequent, and can be of help for the diagnostic orientation. In the adult population, muscle weakness, ophthalmoplegia with ragged-red fibres, retinitis pigmentosa, progressive myoclonal ataxia, and early-onset stroke-like episodes, are frequently combined in complex syndromes that are often familial (maternally inherited) and/or associated with well-established mutations in mitochondrial DNA (mtDNA). However, the presence of overlap syndromes and features common to many neuromitochondrial diseases can complicate the clinical evaluation and the diagnostic approach. The pathogenicity of a given mtDNA mutation can frequently be ascertained by correlating the degree of heteroplasmy with the clinical or biochemical phenotypes. Moreover, transmitochondrial cybrids can be used to test the effects of either mitochondrial or nuclear gene abnormalities in a fully controlled, user-friendly and highly informative system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8884574     DOI: 10.1007/BF01799111

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  35 in total

1.  Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.

Authors:  Y Tatuch; J Christodoulou; A Feigenbaum; J T Clarke; J Wherret; C Smith; N Rudd; R Petrova-Benedict; B H Robinson
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

2.  Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR).

Authors:  M Zeviani; C Gellera; C Antozzi; M Rimoldi; L Morandi; F Villani; V Tiranti; S DiDonato
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

3.  Mitochondrial dysfunction in multiple symmetrical lipomatosis.

Authors:  S F Berkovic; F Andermann; E A Shoubridge; S Carpenter; Y Robitaille; E Andermann; C Melmed; G Karpati
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

4.  The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria.

Authors:  Y Tatuch; B H Robinson
Journal:  Biochem Biophys Res Commun       Date:  1993-04-15       Impact factor: 3.575

5.  The 8993 mtDNA mutation: heteroplasmy and clinical presentation in three families.

Authors:  Y Tatuch; R A Pagon; B Vlcek; R Roberts; M Korson; B H Robinson
Journal:  Eur J Hum Genet       Date:  1994       Impact factor: 4.246

6.  Progressive myoclonus epilepsies: an electroclinical, biochemical, morphological and molecular genetic study of 17 cases.

Authors:  S Franceschetti; C Antozzi; S Binelli; F Carrara; N Nardocci; M Zeviani; G Avanzini
Journal:  Acta Neurol Scand       Date:  1993-03       Impact factor: 3.209

Review 7.  Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis.

Authors:  S F Berkovic; N K So; F Andermann
Journal:  J Clin Neurophysiol       Date:  1991-07       Impact factor: 2.177

8.  A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy.

Authors:  G Silvestri; F M Santorelli; S Shanske; C B Whitley; L A Schimmenti; S A Smith; S DiMauro
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

9.  Nuclear DNA origin of cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence based on patient's-derived rho degrees transformants.

Authors:  V Tiranti; M Munaro; D Sandonà; E Lamantea; M Rimoldi; S DiDonato; R Bisson; M Zeviani
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

10.  An autosomal locus predisposing to deletions of mitochondrial DNA.

Authors:  A Suomalainen; J Kaukonen; P Amati; R Timonen; M Haltia; J Weissenbach; M Zeviani; H Somer; L Peltonen
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

View more
  17 in total

Review 1.  Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

2.  Phenotype variability in 130 adult patients with respiratory chain disorders.

Authors:  J Finsterer; C Jarius; H Eichberger
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

3.  Multiple presentation of mitochondrial disorders.

Authors:  A Nissenkorn; A Zeharia; D Lev; A Fatal-Valevski; V Barash; A Gutman; S Harel; T Lerman-Sagie
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

4.  Iron deficiency in children with mitochondrial disease.

Authors:  Hye Eun Kwon; Jung Hun Lee; Young Mock Lee; Hoon Chul Kang; Joon Soo Lee; Heung Dong Kim
Journal:  Metab Brain Dis       Date:  2010-04-28       Impact factor: 3.584

5.  Mitochondrial respiratory chain defects are not accompanied by an increase in the activities of lactate dehydrogenase or manganese superoxide dismutase in paediatric skeletal muscle biopsies.

Authors:  I P Hargreaves; S J Heales; J M Land
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

Review 6.  Mitochondrial disorders: prevalence, myths and advances.

Authors:  D R Thorburn
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

7.  Clinical presentations of mitochondrial cardiomyopathies.

Authors:  D Lev; A Nissenkorn; E Leshinsky-Silver; M Sadeh; A Zeharia; B-Z Garty; L Blieden; V Barash; T Lerman-Sagie
Journal:  Pediatr Cardiol       Date:  2004-06-08       Impact factor: 1.655

8.  Targeted metabolomics highlights perturbed metabolism in the brain of autism spectrum disorder sufferers.

Authors:  Stewart F Graham; Onur Turkoglu; Ali Yilmaz; Ilyas Ustun; Zafer Ugur; Trent Bjorndhal; BeomSoo Han; Rupa Mandal; David Wishart; Ray O Bahado-Singh
Journal:  Metabolomics       Date:  2020-04-24       Impact factor: 4.290

9.  MitoLSDB: a comprehensive resource to study genotype to phenotype correlations in human mitochondrial DNA variations.

Authors:  Shamnamole K; Saakshi Jalali; Vinod Scaria; Anshu Bhardwaj
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Dysfunction in Mitochondrial Electron Transport Chain Complex I, Pyruvate Dehydrogenase Activity, and Mutations in ND1 and ND4 Gene in Autism Spectrum Disorder Subjects from Tamil Nadu Population, India.

Authors:  Iyer Mahalaxmi; Mohana Devi Subramaniam; Abilash Valsala Gopalakrishnan; Balachandar Vellingiri
Journal:  Mol Neurobiol       Date:  2021-07-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.